_version_ 1784577790570397696
author Cortelazzo, Sergio
Mian, Michael
Evangelista, Andrea
Devizzi, Liliana
Corradini, Paolo
Magni, Michele
Ladetto, Marco
Ferrero, Simone
Rossi, Andrea
Barbui, Anna Maria
Patti, Caterina
Costa, Alessandro
Vitolo, Umberto
Chiappella, Annalisa
Benedetti, Fabio
Ferreri, Andrés J. M.
Nicoli, Paolo
Rigacci, Luigi
Castellino, Claudia
Gianni, Alessandro M.
Rambaldi, Alessandro
Tarella, Corrado
author_facet Cortelazzo, Sergio
Mian, Michael
Evangelista, Andrea
Devizzi, Liliana
Corradini, Paolo
Magni, Michele
Ladetto, Marco
Ferrero, Simone
Rossi, Andrea
Barbui, Anna Maria
Patti, Caterina
Costa, Alessandro
Vitolo, Umberto
Chiappella, Annalisa
Benedetti, Fabio
Ferreri, Andrés J. M.
Nicoli, Paolo
Rigacci, Luigi
Castellino, Claudia
Gianni, Alessandro M.
Rambaldi, Alessandro
Tarella, Corrado
author_sort Cortelazzo, Sergio
collection PubMed
description
format Online
Article
Text
id pubmed-8486659
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84866592021-10-13 Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term Cortelazzo, Sergio Mian, Michael Evangelista, Andrea Devizzi, Liliana Corradini, Paolo Magni, Michele Ladetto, Marco Ferrero, Simone Rossi, Andrea Barbui, Anna Maria Patti, Caterina Costa, Alessandro Vitolo, Umberto Chiappella, Annalisa Benedetti, Fabio Ferreri, Andrés J. M. Nicoli, Paolo Rigacci, Luigi Castellino, Claudia Gianni, Alessandro M. Rambaldi, Alessandro Tarella, Corrado Bone Marrow Transplant Correspondence Nature Publishing Group UK 2021-07-07 2021 /pmc/articles/PMC8486659/ /pubmed/34234297 http://dx.doi.org/10.1038/s41409-021-01391-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Cortelazzo, Sergio
Mian, Michael
Evangelista, Andrea
Devizzi, Liliana
Corradini, Paolo
Magni, Michele
Ladetto, Marco
Ferrero, Simone
Rossi, Andrea
Barbui, Anna Maria
Patti, Caterina
Costa, Alessandro
Vitolo, Umberto
Chiappella, Annalisa
Benedetti, Fabio
Ferreri, Andrés J. M.
Nicoli, Paolo
Rigacci, Luigi
Castellino, Claudia
Gianni, Alessandro M.
Rambaldi, Alessandro
Tarella, Corrado
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
title Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
title_full Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
title_fullStr Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
title_full_unstemmed Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
title_short Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
title_sort upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486659/
https://www.ncbi.nlm.nih.gov/pubmed/34234297
http://dx.doi.org/10.1038/s41409-021-01391-x
work_keys_str_mv AT cortelazzosergio upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT mianmichael upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT evangelistaandrea upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT devizzililiana upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT corradinipaolo upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT magnimichele upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT ladettomarco upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT ferrerosimone upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT rossiandrea upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT barbuiannamaria upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT patticaterina upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT costaalessandro upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT vitoloumberto upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT chiappellaannalisa upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT benedettifabio upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT ferreriandresjm upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT nicolipaolo upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT rigacciluigi upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT castellinoclaudia upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT giannialessandrom upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT rambaldialessandro upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm
AT tarellacorrado upfrontintensivechemoimmunotherapywithautograftin199adultmantlecelllymphomapatientsprolongedsurvivalandcurepotentialityatlongterm